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Abstract We describe the synthesis and purification of
two functional peptides, namely human insulin-like
growth factor II (IGF-II) and Xenopus laevis magainin
II in Hansenula polymorpha after their synthesis as
hybrid proteins fused to the C terminus of endogenous
amine oxidase. The hybrid genes, placed under control
of the H. polymorpha alcohol oxidase promoter (P
AOX
),
were integrated into the genomic alcohol oxidase locus,
yielding stable production strains. High-level synthesis
of the fusion proteins, exceeding 20% of total cellular
protein, was obtained when the transformed strains
were grown in methanol-limited chemostat cultures;
when expressed by itself, i.e. in the absence of the amine
oxidase gene, IGF-II could not be recovered from
crude cell extracts, probably as a result of rapid pro-
teolytic degradation. Accumulation in peroxisomes did
not significantly affect the IGF-II protein stability
when expressed in the absence of the carrier protein.
Apparently, fusion to the large ($78 kDa) amine
oxidase carrier particularly stabilizes the peptides and
prevents them from proteolysis. After partial purifica-
tion, the fusion partners were readily separated by
factor Xa treatment.
Introduction
The methylotrophic yeast Hansenula polymorpha has
been developed as an attractive host for the production
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of foreign proteins. High-level synthesis of such pro-
teins was obtained by expressing their cognate genes
from strong endogenous promoters e.g. the alcohol
oxidase promoter (Buckholz and Gleeson 1991; Gellis-
sen et al. 1992).
In methanol-grown cells of H. polymorpha, the key
enzyme of methanol catabolism, alcohol oxidase is
compartmentalized in peroxisomes (Veenhuis and
Harder 1991). These organelles occupy a major part (up
to 80%) of the cytoplasmic volume under these condi-
tions and hence may provide a potential storage site for
heterologous proteins. This approach is thought to be
of particular advantage when cytosolic synthesis leads
to foreign protein instability and/or causes undesirable
effects on the viability of the host.
In order to verify this assumption, we have syn-
thesized two small functional peptides in H. poly-
morpha, namely human insulin-like growth factor II
(IGF-II) and Xenopus laevis magainin II (MAG-II),
either as independent peptides or fused to peroxisomal
amine oxidase (AMO) as carrier protein. IGF-II is
a 67-amino acid single-chain polypeptide of 7.5 kDa,
which structurally resembles insulin. Synthesis of IGF-
I by S. cerevisiae has been shown to cause severe toxic
effects on the host (Bayne et al. 1988; Shuster et al.
1989). Similar effects are expected for the structurally
homologous IGF-II and this was therefore chosen as
model peptide in our packaging approach. Magainin II
is a 23-amino-acid peptide which is found in skin secre-
tions of the African clawed frog X. laevis (Zasloff 1987;
Moore et al. 1991). It belongs to the class of antimic-
robial peptides that are synthesized by higher eu-
karyotes as a defence against microbial invasion. The
precise action of these antibiotics is unclear but it is
known that they rapidly permeabilize phospholipid
vesicles (Grant et al. 1992). Because of this activity,
biological production of these peptides in their mature
and active form is thought to be impossible and hence it
is taken as the second model protein. The results of this
work are detailed in this paper.
Materials and methods
Strains and cultivation
All strains used in this study are listed in Table 1. Transformants of
H. polymorpha A16, carrying hybrid genes coding for AMO-IGF-II
(GF37), AMO-MAG-II (GF70) or IGF-II-SKL (GF33) (where SKL
is the peroxisomal targeting signal, Ser-Lys-Leu) under the control
of the H. polymorpha alcohol oxidase promoter (P
AOX
), were grown
in carbon-source-limited chemostat cultures on mineral medium
containing glucose (0.25% w/v) plus methanol (0.25% v/v) as carbon
sources and ammonium sulphate (0.25% w/v) as the nitrogen source





IGF-II) were grown in shake flasks in mineral
medium on methanol (0.5% v/v) as a carbon source and ammonium
sulphate (0.25% w/v) as the nitrogen source (Veenhuis et al. 1979).
Molecular genetics and yeast transformation
All genetic manipulations were performed according to standard
procedures (Sambrook et al. 1989). DNA fragments obtained by the
polymerase chain reaction (PCR) and synthetic DNA fragments
were sequenced using the T7 sequencing kit from pharmacia
(Uppsala, Sweden). E. coli DH5a was used as host for plasmid
amplification. H. polymorpha A16 was transformed by electropora-
tion (Faber et al. 1994a). Forced integration of linearized plasmid
DNA into the yeast genome was performed as described earlier
(Faber et al. 1992, 1994b).
Plasmid constructions
A schematic representation of the heterologous (hybrid) genes used
in this study is shown in Fig. 1. The gene encoding mature human
IGF-II was adapted by PCR, using the oligonucleotides listed in
Table 2. With oligonucleotides 1 and 2, a XhoI site and the sequence
encoding the factor Xa recognition site, -Ile-Glu-Gly-Arg-(-IEGR-),
were introduced in front of the IGF-II coding sequence. In addition,
a stop codon was introduced behind the codon for Glu67, followed
by a SacI site. With oligonucleotides 1 and 3, a DNA fragment was
obtained coding for IGF-II preceded by the XhoI/-IEGR- sequence
and followed by a fragment encoding the C-terminal dodecapeptide
of firefly luciferase, containing the SKL-COOH peroxisomal target-
ing signal (PTS1). A gene encoding IGF-II preceded by an NcoI
restriction site and a translation start codon was synthesized by
using oligonucleotides 2 and 4. A gene coding for IGF-II fused to the
sequence encoding the C-terminal dodecapeptide of firefly luciferase
Table 1 Hansenula polymorpha strains used in this study. P
AOX
alco-
hol oxidase promoter, IGF-II insulin-like growth factor II, SK¸
Ser-Lys-Leu, the peroxisomal targeting signal, AMO amine oxidase,
MAG-II magainin II
H. polymorpha Genotype Reference
A16 leu1.1 Veale et al. 1992
GF16 P
AOX
AMO Faber et al. 1994c
GF33 pGF88 : P
AOX
IGF-II-SKL This study
GF37 pGF151 : P
AOX
AMO-IGF-II This study
GF38 pGF156 : P
AOX
IGF-II This study








Fig. 1 Schematic representation of the gene constructs encoding
heterologous proteins. The restriction sites used for gene construc-
tion and insertion into the expression vector pHIPX2 are indicated.
Open box amine oxidase (AMO) sequences; hatched box insulin-like
growth factor II (IGF-II) sequences; solid box sequence encoding the
C-terminal dodecapeptide of firefly luciferase; dotted box magainin
II (MAG-II) sequences. Arrow the factor Xa cleavage site. H HindIII,
N Nco I, S SacI, X XhoI
was synthesized by using oligonucleotides 3 and 4. A synthetic DNA
fragment coding for the XhoI/-IEGR- sequence followed by the
open-reading frame of magainin II (GIGKFLHSAKKFGKAF-
VGEIMNS) was constructed using the oligonucleotides listed in
Table 2.
The PCR fragments and the synthetic DNA fragment were cloned
as XhoI and SacI fragments in pOK12 (Vieira and Messing 1991)
digested with the same restriction enzymes. After the sequence of the
DNA inserts had been confirmed, they were cloned behind the
amine oxidase gene and fused at the XhoI site present at the codon
for Val680 (Bruinenberg et al. 1989) and/or cloned behind the
P
AOX
in expression vector pHIPX2 (Faber et al. 1994b). This yielded
pGF88 (pHIPX2#IGF-II-SKL), pGF151 (pHIPX2#AMO-
Table 2 Oligonucleotides used in this study. Italics-Ile-Glu-Gly-
Avg-: factor Xa cleavage site coding sequence; triplets IGF-II or
magainin II coding sequence; bold C
12
luciferase coding sequence;
underlined translation stop codon; lower case translation start codon
IGF-II
1 5@GGCCTCGAGA A¹C GAG GGC AGA GCT TAC
CGC CCC AGT GAG ACC3@
2 5@CGCGAGCTCTTACTC GGA CTT GGC GGG GGT
AG3@
3 5@CCGAGCTCGAGTTA CAG CTT CGA CTT GCC
GCC CTT CTT GGC CTT GAT CAG CTG CAT CTC
GGA CTT GGC GGG GGT AG3@
4 5@GAATTCC atg GCT TAC CGC CCC AGT GAG AC3@
Magainin-II
3754 5@TCG AGA A¹C GAG GGC AGA GGC ATC GGC
AAG TTC CTG CAC TCG GCC AAG AAG3@
3755 5@GA GTG CAG GAA CTT GCC GAT GCC
¹C¹ GCC C¹C GA¹ TC3@
3756 5@TTC GGC AAG GCC TTC GTG GGC GAG ATC
ATG AAC TCG TAAGAGCT3@
3757 5@CTTA CGA GTT CAT GAT ATC GCC CAC GAA
GGC CTT GCC GAA CTT CTT GGC C3@
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IGF-II), pGF156 (pHIPX2#IGF-II), pGF158 (pHIPX2#AMO-
IGF-II-SKL) and pGF201 (pHIPX2#AMO-MAG-II).
Biochemical methods
To prepare total cell lysates, cells were washed in 50 mM potassium
phosphate buffer (pH 7.0, 0°C) and subsequently resuspended in
loading buffer used for Sodium dodecyl sulphate/polyacrylamide gel
electrophoresis (SDS-PAGE). After the addition of one-third vol-
ume of acid-washed glass beads, the mixture was vortexed four times
for 2 min with intermittent cooling on ice for 5 min. The homogen-
ate was incubated at 100°C for 5 min and subsequently centrifuged
for 10 min at room temperature in an Eppendorf microfuge
(14000 rpm). The resulting supernatant is referred to as total cell
lysate and was loaded directly onto SDS/polyacrylamide gels. Crude
cell extracts were prepared as described earlier (Waterham et al. 1992).
Total cell lysates and partially purified protein fractions (see
below) were analysed by SDS-PAGE according to Laemmli (1970)
using 7.5% and 15% gels. Gels were stained with Coomassie bril-
liant blue R-250 or subjected to immunoblotting, using the elec-
trogenerated chemoluminescence Western blotting analysis system
(Amersham) and polyclonal antibodies against amine oxidase (1:
5000 dilution), magainin II (1 : 5000 dilution) or monoclonal anti-
bodies against rat IGF-II (1 :1000 dilution) (Sanbio B.V., Uden, The
Netherlands), which cross-react with human IGF-II. Transfer of
proteins onto nitrocellulose (7.5% gels) or PVDF membranes (15%
gels) after SDS-PAGE was performed according to Kyhse-Andersen
(1984), using a semi-dry electroblotter (Ancos, Denmark). Relative
amounts of protein in the total lysates were determined by den-
sitometer scanning with the LKB Ultrascan XL enhanced laser
densitometer. Partially purified fusion proteins (AMO-IGF-II or
AMO-MAG-II) were obtained by differential centrifugation of
crude cell extracts of the transformed strains at 4°C. The extract was
centrifuged for 5 min at 2500 rpm. The supernatant was subjected to
differential centrifugation subsequently at 5000 rpm (5 min),
7500 rpm (5 min), 10 000 rpm (5 min) and 14 000 rpm (15 min). The
pellets were resuspended in 50 mM potassium phosphate buffer
(pH 7.0).
Proteolytic cleavage of the fusion protein with factor Xa was
performed as described in the protein fusion and purification system
(Biolabs) except that 0.5% Tween 20 (or 0.5% Triton X-100) was
added to the cleavage buffer. The biological activity of magainin II
was determined by a modified plate assay (Zasloff 1987; Moore et al.
1991). E. coli strain DH1 was spread onto a LB plate. A dilution
series of samples containing (a) pure magainin II (Bachem, Switzer-
land), (b) AMO-MAG-II fusion protein, (c) the cleaved fusion pro-
tein and (d) AMO-IGF-II fusion protein (used as negative control)
were spotted on this plate and incubated overnight at 37°C.
Electron microscopy
Intact cells were prepared for electron microscopy as described by
Keizer-Gunnink et al. (1992). Immunocytochemical experiments
were performed on ultrathin sections of Unicryl-embedded cells
using polyclonal antibodies raised against amine oxidase and dihyd-
roxyacetone synthase and gold-conjugated goat anti-(rabbit Ig) anti-
bodies.
Results
Transformation and strain selection
Prior to transformation, all expression plasmids were
linearized to force targeted integration of the plasmid
DNA into the genomic alcohol oxidase locus as de-
scribed previously (Faber et al. 1992, 1994b). A normal
expression level of the endogenous alcohol oxidase
protein was maintained. Transformants were subjected
to Southern blot analysis to determine the chromo-
somal configuration (data not shown). Five strains,
designated GF33 (IGF-II-SKL), GF37 (AMO-IGF-II),
GF38 (IGF-II), GF42 (AMO-IGF-SKL) and GF70
(AMO-MAG-II) were selected, which contained two to
three copies of the respective expression plasmids in the
genome. All strains grew well on various substrates,
including methanol. However, the cell yield of GF70
(expressing AMO-MAG-II) in methanol-limited chemo-
stat cultures was approximately 20% reduced, com-
pared to identically grown GF37 and WT control cells.
Production and intracellular location
of the amine oxidase/small functional peptide
fusion proteins
To obtain maximal expression levels of the AMO-IGF-
II and AMO-MAG-II fusion genes, the transformants
GF37 and GF70, respectively, were grown in meth-
anol-limited chemostat cultures. In Coomassie-bril-
liant-blue-stained SDS/polyacrylamide gels containing
total cell lysates of both transformants, an extra protein
band of the expected size was present in addition to
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Fig. 2A,B SDS-PAGE analysis of total cell lysates of strain GF16
(lane 1 over-expression of amine oxidase), GF37 (lane 2 expression of
AMO-IGF-II) and GF70 (lane 3 expression of AMO-MAG-II).
Cells were grown in chemostat cultures on glucose/methanol/am-
monium sulphate. A Coomassie-brilliant-blue-stained gel. Proteins
with approximate sizes of 78 kDa (amine oxidase), 85 kDa (AMO-
IGF-II) and 80 kDa (AMO-MAG-II) are clearly visible above the
dominant alcohol oxidase band at 75 kDa. B Western blots of the
lysates presented in A. The fusion proteins were recognized by
antibodies against amine oxidase (a-AMO, lane 1), IGF-II (a-IGF-II,
lane 2) and magainin II (a-MAG-II, lane 3)
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those present in identical preparations of strain GF16,
expressing amine oxidase by the P
AOX
(Fig. 2A): an
85-kDa band for the AMO-IGF-II fusion protein and
a 80-kDa band for the AMO-MAG-II fusion protein.
In Western blots these bands were recognized by anti-
bodies against amine oxidase and antibodies raised
against the specific heterologous SFP, IGF-II and
MAG-II respectively (Fig. 2B).
The levels of the AMO-IGF-II fusion protein were
determined by densitometry of the Coomassie-bril-
liant-blue-stained SDS/polyacrylamide gels (Fig. 2A,
lane 2), showing that AMO-IGF-II constituted approx-
imately 21% of the total cellular protein. As is evident
from Fig. 2A, comparable levels were obtained for
AMO-MAG-II. Remarkably, no IGF-II protein was
detected when it was expressed as a separate peptide
in the absence of the amine oxidase carrier (see Fig. 1).
Also IGF-II fused to a PTS1 signal (SKL), could not be
detected by SDS-PAGE or Western blotting. Northern
blot analysis, however, showed that the corresponding
transcript was synthesized. Therefore, we assume that
IGF-II is rapidly degraded after its synthesis (data not
shown).
The morphology of strains GF37 and GF70 and the
subcellular location of the fusion proteins were studied
by ultrastructural techniques. Since the N-terminal
amine oxidase sequence present in the fusion proteins
contains the topogenic information necessary for per-
oxisomal targeting (Faber et al. 1995b), we anticipated
Fig. 3A±D Ultrastructural analysis of the AMO-IGF-II-producing
strain GF37 grown in chemostat cultures on glucose/methanol/am-
monium sulphate (A—C). Cells contain many peroxisomes together
with large cytosolic proteinaceous aggregates (*) (A). These protein
aggregates are intensively labelled in immunocytochemical experi-
ments using anti-AMO, indicating that the fusion protein is not
imported into peroxisomes (B). After incubation with anti-(dihyd-
roxyacetone synthase), only peroxisomes are labelled (C).
Cytochemical demonstration of endogenous amine oxidase in per-
oxisomes of cells of strain GF37, grown on methanol/methylamine
(Ce3`#methylamine) (D). N nucleus P peroxisome. Bars 0.5 lm
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that the fusion product would accumulate, at least
partly, in these organelles. However, in strain GF37 the
AMO-IGF-II fusion protein was located in the cytosol
in a loose aggregate, which frequently occupied a major
part of the cytoplasm (Fig. 3A). This was evident from
immunocytochemical experiments, which revealed that
these structures were densely labelled using anti-AMO
antibodies; peroxisomes invariably were not labelled
(Fig. 3B). In strain GF70, expressing AMO-MAG-II,
proteinaceous aggregates were not observed. Instead,
strong proliferation of interconnected membranes had
occurred; since these membraneous networks were con-
tinuous with the nuclear membrane, they are con-
sidered to be derived from the endoplasmic reticulum
(Fig. 4A). In addition, in many cells focal thickenings of
the cell wall were observed (Fig. 4B). Immunocyto-
chemically, using anti-AMO antibodies, specific labell-
ing was observed on the membraneous networks but
not on the cell wall outgrowths, indicating that the
fusion protein was associated with these membranes
(Fig. 4C); as with AMO-IGF-II, no peroxisomal labell-
ing was observed. In both strains the import of homo-
logous peroxisomal matrix proteins (e.g. alcohol
oxidase, dihydroxyacetone synthase and catalase) was
not affected as was evident from immunocytochemistry
(shown for dihydroxyacetone synthase in strain GF37;
Fig. 3C).
Similar results were obtained with cells grown in the
presence of methylamine, a condition which is known
to induce the PTS2 import machinery maximally
(Faber et al. 1994b). These results indicate that, despite
the presence of peroxisomal targeting information, the
hybrid proteins are not correctly sorted, presumably as
a result of the addition of the heterologous peptides to
the amine oxidase C terminus. However, normal per-
oxisomal import of AMO-IGF-II was accomplished
when the hybrid protein was subsequently fused to the
C-terminal dodecapeptide of firefly luciferase contain-
ing the PTS1 sequence, SKL (Fig. 4D). Apparently, the
Fig. 4A±C Ultrastructural analysis of the AMO-MAG-II-produ-
cing strain GF70 grown in thermostat cultures on glucose/meth-
anol/ammonium sulphate. In the cells a strong proliferation of
membranes (A) and/or focal thickenings of the cell wall (B) were
observed. Immunocytochemically, using anti-AMO, membrane
structures were specifically labelled (C). The low labelling intensity is
characteristic for these cells and probably reflects the fact that the
antigenic epitopes are, at least partly, hidden in the membranes. D In
methanol-grown cells of strain GF42, the AMO-IGF-II-SKL hybrid
protein is located in peroxisomes (anti-AMO). N nucleus, P peroxi-
some. Bars 0.5 lm, or stated otherwise
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amine oxidase fusion proteins are structurally not
amenable to import via the PTS2 import pathway.
Purification of the fusion proteins
The fact that the AMO-IGF-II fusion protein was
present in proteinaceous aggregates facilitated its puri-
fication. Highly purified fusion protein (more than
90%) could be obtained by differential centrifugation of
a crude extract of methanol-grown GF37 cells
(Fig. 5A). The insoluble (14 000 rpm pellet) fraction
comprised approximately 50% of the total AMO-IGF-
II fusion protein synthesized in these cells. The same
procedure applied to methanol-grown GF70 also yiel-
ded partially purified AMO-MAG-II, probably
because of the partial enrichment of the complex mem-
branous structures in the 14 000 rpm pellet (Fig. 5B).
Subsequently both fractions containing either the
insoluble (lanes 6, Fig. 5A,B) or soluble (lanes 7,
Fig. 5A,B) fusion proteins were subjected to factor Xa
digestion to release the heterologous peptides from the
amine oxidase carrier protein. After 4 h of incubation of
the insoluble fraction in the presence of factor Xa at
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Fig. 5A,B SDS-PAGE of protein fractions obtained after differen-
tial centrifugation of crude extracts of strain GF37 (A) and GF70 (B).
¸anes 1 total cell extract; lanes 2 2500 rpm pellet; lanes 3 5000 rpm
pellet; lanes 4 7500 rpm pellet; lanes 5 10 000 rpm pellet; lanes
6 14 000 rpm pellet; lanes 7 14 000 rpm supernatant. As can be seen
in lanes 6, the 14 000 rpm pellet fraction is enriched in the specific
fusion protein
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Fig. 6A,B Factor Xa treatment of fractions containing partially
purified fusion protein. Starting material was a 30 000 g pellet frac-
tion which also contained, besides the fusion protein, alcohol
oxidase. A Part of a Coomassie-brilliant-blue-stained gel (7.5%
polyacrylamide). Protein fractions were loaded before (lanes 1, 3)
and after (lanes 2, 4) 4 h of incubation with factor Xa. ¸anes 1, 2
fractions from strain GF37 (AMO-IGF-II), lanes 3, 4 fractions from
strain GF70 (AMO-MAG-II). Arrowhead the position of alcohol
oxidase and the amine oxidase carrier protein after factor Xa treat-
ment. B Western blot of fractions 1 and 2 from A. These fractions
were loaded on a 15% polyacrylamide gel and, after transfer to
PVDF membranes, decorated with monoclonal antibodies against
rat IGF-II. The reacting band, seen in lane 2, shows the same
electrophoretic mobility as pure human IGF-II used as a control
(not shown)
30°C, over 90% of the AMO-IGF-II or AMO-MAG-II
fusions was effectively digested (Fig. 6A) and the het-
erologous peptide was released from the carrier protein
(shown for IGF-II, Fig. 6B). Similar results were
obtained with the soluble fractions (data not shown).
The AMO-MAG-II hybrid protein, produced by
H. polymorpha, displayed antimicrobial activity. This
could be clearly demonstrated in a plate assay, using
E. coli DH1 as the indicator strain. After the plates had
been spotted with various amounts of 14 000 rpm
supernatants, containing the soluble part of AMO-
MAG-II, clear halos readily appeared at the sites where
these fractions had been spotted (data not shown).
Discussion
In this paper we describe the use of the methylotrophic
yeast H. polymorpha as a possible host for the hetero-
logous expression of small functional peptides. In
recent years, microbiological production of small pep-
tides has gained interest as a low-cost alternative for
chemical synthesis. However, the development of effi-
cient heterologous expression systems has met several
problems, ranging from unexpectedly low yields due to
intracellular proteolytic degradation of the foreign gene
product to undesirable effects of the heterologous prod-
ucts on the viability of the cells. In part, these problems
could be overcome by the selection of suitable produc-
tion strains by classical mutagenesis, as for instance in
the case of IGF-I produced by baker’s yeast (Shuster et
al. 1989). We have followed a different strategy to
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synthesize small peptides by fusing them to the endo-
genous amine oxidase, for which we had already estab-
lished a high level of expression in H. polymorpha
(Faber et al. 1994b). Furthermore, this approach al-
lowed us to study the possible advantage of the accu-
mulation of the hybrid proteins in peroxisomes.
The two proteins tested, human insulin-like growth
factor-II (IGF-II) and magainin II (MAG-II) from
X. laevis, were synthesized at high levels (about 20% of
the total protein) in fusion with amine oxidase. Unex-
pectedly, neither of the fusion proteins was imported
into peroxisomes. As shown before (Faber et al.
1993, 1995b), amine oxidase is a typical PTS2 protein,
the import of which is not affected by small deletions of
the C terminus. Our data lead us to conclude that the
addition of IGF-II and magainin II to the C terminus
of amine oxidase specifically interfered with proper
targeting via the PTS2 import machinery. This view is
based on the findings that (a) the PTS2 import
machinery functions efficiently in the transformed
strains, since homologous amine oxidase was normally
imported, and (b) the AMO-IGF-II hybrid protein
was correctly imported when a PTS1 (SKL) was sub-
sequently fused to the C terminus of the hybrid protein.
This indicates that IGF-II, in principle, can be
imported.
Attempts to synthesize IGF-II as the single peptide
in the same expression system failed. Even when fused
to a PTS1 sequence (SKL), IGF-II was not detected in
crude extracts. As transcription of the heterologous
genes was observed, judged from Northern blot analy-
sis (data not shown), the protein is probably rapidly
degraded after synthesis. Although the AMO-IGF-II
fusion protein did not accumulate in peroxisomes, sig-
nificant amounts of IGF-II were produced in fusion
with the amine oxidase carrier protein. Apparently
IGF-II is less susceptible to proteolysis in this hybrid
form. Therefore, compartmentalization of the protein
was not essential to avoid proteolytic degradation of
the heterologous fusion protei.
The 23-amino-acid peptide magainin II from
X. laevis was also synthesized to high levels in the same
expression system. As for AMO-IGF-II, partial purifi-
cation and factor Xa cleavage of the fusion protein were
readily achieved. However, the morphological response
to AMO-MAG-II synthesis in H. polymorpha was
remarkably different. First, strong endoplasmic re-
ticulum proliferation was observed. Since the fusion
protein appeared to be associated with these structures,
this suggests that the magainin part of the hybrid
protein drives its insertion into the membrane. Second-
ly, often a focal cell wall thickening was observed.
Similar structures have often been observed in my-
coparasitic systems where they are considered to reflect
a response of the cell to a toxic substance or enzyme
(Persson et al. 1985). By analogy, the cell wall prolifer-
ation in H. polymorpha may be a response to
the high intracellular antibiotic concentration. The
antimicrobial activity of the AMO-MAG-II fusion pro-
tein was indeed maintained, as was demonstrated in
a qualitative plate assay. Although this activity was not
lethal for the H. polymorpha cells, it may very well
explain the lower cell yields observed for the cells
synthesizing AMO-MAG-II.
In conclusion, we have developed a suitable system
for the biological synthesis of small functional peptides
in the methylotrophic yeast H. polymorpha. The hetero-
logous peptides were synthesized fused with an endo-
genous carrier protein but could be readily released
from this partner by proteolytic (factor Xa) treatment.
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